Equity Brief: Ratings Changes for November 27th: SRPT, TRV, TSRX, URBN, VICL, VPHM, VSAT, WWW

Tue Nov 27, 2012 10:18am EST

* Reuters is not responsible for the content in this press release.

A number of stocks were upgraded and downgraded by equities research analysts today, as reported by Analyst Ratings Network (http://bit.ly/equitybriefdaily) and Equity Brief:

Burrill Institutional Research initiated coverage on shares of Sarepta Therapeutic (NASDAQ: SRPT). They issued an outperform rating on the stock and set a $54.00 price target.

Zacks downgraded shares of The Travelers Companies, Inc. (NYSE: TRV) from an outperform rating to a neutral rating. Their analysts now have a $75.00 price target on the stock. Zacks' analyst wrote, "We are downgrading Travelers to Neutral from Outperform as we remain concerned about its fourth quarter results being negatively affected due to the catastrophe loss owing to Superstorm Sandy. Travelers third quarter earnings outperformed our expectations due to lower catastrophe losses, sturdy underwriting results and solid investment income. Top line also surpassed our expectations, driven by the augmentation in premiums earned and net investment income. Based on a high retention rate, pricing gains, positive renewal rate changes, prudent underwriting practice, strong capital position and strong ratings, Travelers is poised to perform better going forward. Travelers' continuous share buyback strategy has a positive impact on earnings per share and also bolsters shareholder value. Also, the quarter experienced improvement in the debt capital ratio. "

Leerink Swann initiated coverage on shares of Trius Therapeutics Inc (NASDAQ: TSRX). They issued an outperform rating on the stock.

Zacks downgraded shares of Urban Outfitters, Inc. (NASDAQ: URBN) from an outperform rating to a neutral rating. Their analysts now have a $40.00 price target on the stock.

Citigroup initiated coverage on shares of Vical Incorporated (NASDAQ: VICL). They issued a buy rating on the stock and set a $6.00 price target.

Leerink Swann upgraded shares of ViroPharma Incorporated (VPHM) from a market perform rating to an outperform rating. Leerink Swann now has a $30.00 price target on the stock, up previously from $27.00.

Macquarie upgraded shares of ViaSat (VSAT) from an underperform rating to a neutral rating. Macquarie now has a $32.00 price target on the stock.

Goldman Sachs initiated coverage on shares of Wolverine World Wide (WWW). They issued a neutral rating on the stock and set a $43.00 price target.

Cantor Fitzgerald upgraded shares of Yelp (YELP) from a hold rating to a buy rating. Cantor Fitzgerald now has a $24.00 price target on the stock.

Stay on top of analysts' coverage with Analyst Ratings Network's free daily email newsletter that provides a concise list of analysts' upgrades, downgrades and initiations. Register at http://bit.ly/equitybriefdaily

Content and Media Contact: newseditor@equitybrief.net





This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: Equity Brief via Thomson Reuters ONE

HUG#1660847
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.